HEMEX Benelux
Vital Decosterstraat 16
3000 Leuven
BE
HEMEX Benelux
Foundation date
01/09/2023
Sector
#Biotechnology / R&D ServicesSubsector
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the nervous system
- #Infectious and parasitic diseases
- #Musculoskeletal system and connective tissue
- #Neoplasms / cancer / oncology
- #Pregnancy - childbirth and the puerperium
- #Respiratory system
- #Skin and subcutaneous tissue
HEMEX, a CRO, provides clinical development services for healthcare SMEs, covering phases from late pre-clinical to phases I-IV, CE-mark applications, and post-market clinical investigations. Our extensive track record encompasses diverse therapeutic areas, including pharmaceuticals, biotechnology, medical devices, IVDs, and digital health. Collaborating with universities, hospitals, professionals, patient groups, and corporations, we have excelled in clinical, regulatory, and quality projects.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator